Regulatory framework in Pakistan: situation analysis of medicine quality and future recommendations
Background Quality issues in pharmaceuticals are identified as a huge global and public health problem, especially with reference to low- and middle-income countries like Pakistan. The 2011 "Fake Drug Crisis" acted as a driving force to reform the regulatory structures of the country and f...
Saved in:
Main Authors: | Huma Rasheed (Author), Ludwig Hoellein (Author), Khalid Saeed Bukhari (Author), Ulrike Holzgrabe (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2019-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Future Information Technology Tools for Fighting Substandard and Falsified Medicines in Low- and Middle-Income Countries
by: Huma Rasheed, et al.
Published: (2018) -
Breast Cancer in Pakistan: Alarming Situation of Breast Cancer in Near Future
by: Muhammad ARIF, et al.
Published: (2020) -
Ocular medicines in children: the regulatory situation related to clinical research
by: Fortinguerra Filomena, et al.
Published: (2012) -
Availability of medical supplies during the 2010 Pakistan floods
by: David Tordrup, et al.
Published: (2013) -
Foreign regulatory recommendations
Published: (2022)